SCHEMBL7376302

SCHEMBL7376302

O=C(CC(CCCc1ccccc1)C(=O)O)c1ccc(-c2ccc(OCc3ccccc3)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.56
FFAR1 O14842 3/20 0.50
NR4A1 P22736 1/20 0.50
NR4A2 P43354 1/20 0.50
NR4A3 Q92570 1/20 0.50
MAOB P27338 1/20 0.48
PARP10 Q53GL7 1/20 0.48
LTA4H P09960 1/20 0.48
EPHX2 P34913 1/20 0.48
EGFR P00533 2/20 0.47
ALOX5 P09917 1/20 0.47
SRD5A2 P31213 1/20 0.47
FFAR4 Q5NUL3 1/20 0.47
ALDH1A1 P00352 1/20 0.45
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
PLA2G4B P0C869 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7378044 1.00 MMP12 (0.56) MMP12FFAR1NR4A1NR4A2NR4A3
SCHEMBL7376996 1.00 MMP12 (0.56) MMP12FFAR1NR4A1NR4A2NR4A3
SCHEMBL6411354 0.88 TSHR (0.54) MMP12RAB9AGRIK1
SCHEMBL7372219 0.87 RARB (0.53) ALOX5MAPTRAB9ASMN1; SMN2PLA2G4B
SCHEMBL6412929 0.87 RARB (0.53) ALOX5MAPTRAB9ASMN1; SMN2PLA2G4B
SCHEMBL7377067 0.87 RARB (0.53) ALOX5MAPTRAB9ASMN1; SMN2PLA2G4B
SCHEMBL6416023 0.86 RARB (0.55) ALOX5ALDH1A1MAPTRAB9APLA2G4B
SCHEMBL8690007 0.85 MMP12 (0.50) MMP12FFAR1NR4A1NR4A2NR4A3
SCHEMBL7371830 0.83 MMP2 (0.60) MAPTGRIK1MCL1
SCHEMBL7347169 0.83 MMP2 (0.60) MAPTGRIK1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0790974-B1 SUBSTITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITIORS BAYER AG (US) 2002-08-14 EP claimed
WO-1996015096-A1 SUBSTITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITIORS BAYER CORPORATION (US) 1996-05-23 WO claimed
EP-0790974-B1 SUBSTITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITIORS BAYER AG (US) 2002-08-14 EP disclosed
US-6166082-A Substituted 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors BAYER CORPORATION (US) 2000-12-26 US disclosed
US-5789434-A ACID, ESTER OR AMIDE DERIVATIVES AS ANTIINFLAMMATORY AGENTS, ANTIARTHRITIC AGENTS AND REDUCTION OF CARTILAGE DETERIORATION BAYER CORPORATION (US) 1998-08-04 US disclosed
EP-0790974-A1 SUBSTITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITIORS Bayer Corporation (US) 1997-08-27 EP disclosed
WO-1996015096-A1 SUBSTITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITIORS BAYER CORPORATION (US) 1996-05-23 WO disclosed